25:
193:
Mak, Lung-Yi; Hui, Rex Wan-Hin; Fung, James; Seto, Wai-Kay; Yuen, Man-Fung (2 November 2023). "Bepirovirsen (GSK3228836) in chronic hepatitis B infection: an evaluation of phase II progress".
247:
99:
140:
169:
242:
252:
120:
35:
218:
210:
129:
202:
149:
236:
222:
54:
206:
173:
74:
44:
214:
24:
18:
49:
39:
139:
119:
114:
98:
93:
85:
80:
128:
8:
73:
148:
195:Expert Opinion on Investigational Drugs
185:
72:
7:
14:
23:
1:
207:10.1080/13543784.2023.2277389
248:Experimental antiviral drugs
269:
170:antisense oligonucleotide
38:, as no other articles
172:developed to treat
77:
16:Pharmaceutical drug
57:for suggestions.
47:to this page from
159:
158:
71:
70:
260:
227:
226:
190:
152:
132:
78:
76:
66:
63:
52:
50:related articles
27:
19:
268:
267:
263:
262:
261:
259:
258:
257:
233:
232:
231:
230:
201:(11): 971–983.
192:
191:
187:
182:
155:
135:
110:
107:Investigational
67:
61:
58:
48:
45:introduce links
28:
17:
12:
11:
5:
266:
264:
256:
255:
250:
245:
235:
234:
229:
228:
184:
183:
181:
178:
157:
156:
154:
153:
145:
143:
137:
136:
134:
133:
125:
123:
117:
116:
112:
111:
109:
108:
104:
102:
96:
95:
91:
90:
87:
83:
82:
69:
68:
55:Find link tool
31:
29:
22:
15:
13:
10:
9:
6:
4:
3:
2:
265:
254:
251:
249:
246:
244:
243:Antisense RNA
241:
240:
238:
224:
220:
216:
212:
208:
204:
200:
196:
189:
186:
179:
177:
175:
171:
167:
163:
151:
147:
146:
144:
142:
138:
131:
127:
126:
124:
122:
118:
113:
106:
105:
103:
101:
97:
92:
88:
84:
81:Clinical data
79:
65:
62:December 2023
56:
51:
46:
42:
41:
37:
32:This article
30:
26:
21:
20:
198:
194:
188:
165:
162:Bepirovirsen
161:
160:
130:1403787-62-1
100:Legal status
94:Legal status
75:Bepirovirsen
59:
33:
253:Hepatitis B
176:infection.
174:hepatitis B
115:Identifiers
86:Other names
237:Categories
180:References
166:GSK3228836
150:Z87O6SM01N
121:CAS Number
89:GSK3228836
53:; try the
40:link to it
223:264672407
43:. Please
215:37902953
168:) is an
221:
213:
36:orphan
34:is an
219:S2CID
211:PMID
141:UNII
203:doi
239::
217:.
209:.
199:32
197:.
225:.
205::
164:(
64:)
60:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
